[HTML][HTML] Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and …
A Babajani, K Moeinabadi-Bidgoli, F Niknejad… - Stem Cell Research & …, 2022 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic …
A Babajani, K Moeinabadi-Bidgoli… - Stem Cell Research & …, 2022 - go.gale.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
[PDF][PDF] Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and …
A Babajani, K Moeinabadi‑Bidgoli, F Niknejad… - 2022 - scienceopen.com
Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), which causes coronavirus
disease 2019 (COVID‑19), has become in the spotlight regarding the serious early and late …
disease 2019 (COVID‑19), has become in the spotlight regarding the serious early and late …
[HTML][HTML] Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and …
A Babajani, K Moeinabadi-Bidgoli… - Stem Cell Research & …, 2022 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic …
A Babajani, K Moeinabadi-Bidgoli… - Stem cell research …, 2022 - pubmed.ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic …
A Babajani, K Moeinabadi-Bidgoli, F Niknejad… - 2022 - agris.fao.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
[HTML][HTML] Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and …
A Babajani… - … Cell Research & …, 2022 - stemcellres.biomedcentral.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic …
A Babajani, K Moeinabadi-Bidgoli… - Stem Cell Research & …, 2022 - europepmc.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic …
A Babajani, K Moeinabadi-Bidgoli… - Stem Cell Research …, 2022 - search.ebscohost.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic …
A Babajani, K Moeinabadi-Bidgoli… - Stem Cell Research …, 2022 - search.proquest.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …
disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late …